SciELO - Scientific Electronic Library Online

 
vol.44 issue1Historical trauma. Systematic review of a different approach to armed conflictEkbom syndrome: apropos of a case author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Psiquiatría

Print version ISSN 0034-7450

Abstract

HUERTAS-RODRIGUEZ, Cindy Katherin; PAYAN-GOMEZ, César  and  FORERO-CASTRO, Ruth Maribel. 22q11.2 DS Syndrome as a Genetic Subtype of Schizophrenia. rev.colomb.psiquiatr. [online]. 2015, vol.44, n.1, pp.50-60. ISSN 0034-7450.  https://doi.org/10.1016/j.rcp.2014.09.002.

Introduction: The 22q11.2 deletion syndrome (22q11.2 DS) is associated with the microdeletion of this chromosomal region, and represents the second most common genetic syndrome after Down's syndrome. In patients with schizophrenia, 22q11.2 DS has a prevalence of 2%, and in selected groups can be increased to between 32-53%. Objective: To describe the generalities of 22q11.2 DS syndrome as a genetic subtype of schizophrenia, its clinical characteristics, molecular genetic aspects, and frequency in different populations. Methods: A review was performed from 1967 to 2013 in scientific databases, compiling articles about 22q11.2 DS syndrome and its association with schizophrenia. Results: The 22q11.2 DS syndrome has a variable phenotype associated with other genetic syndromes, birth defects in many tissues and organs, and a high rate of psychiatric disorders, particularly schizophrenia. Likewise, it has been identified in clinical populations with schizophrenia selected by the presence of common syndromic characteristics. FISH, qPCR and MLPA techniques, and recently, aCGH and NGS technologies, are being used to diagnose this microdeletion. Conclusions: It is important in clinical practice to remember that people suffering the 22q11.2 DS have a high genetic risk for developing schizophrenia, and it is considered that the simultaneous presence of this disease and 22q11.2 DS represents a genetic subtype of schizophrenia. There are clear phenotypic criteria, molecular and cytogenetic methods to diagnose this group of patients, and to optimize a multidisciplinary approach in their monitoring.

Keywords : Schizophrenia; 22q11.2 microdeletion; 22q11.2 deletion syndrome; 22q11.2DS.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )